These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 37884300

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
    Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D, POLA Network.
    Neuro Oncol; 2019 Dec 17; 21(12):1519-1528. PubMed ID: 31832685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
    Felix M, Friedel D, Jayavelu AK, Filipski K, Reinhardt A, Warnken U, Stichel D, Schrimpf D, Korshunov A, Wang Y, Kessler T, Etminan N, Unterberg A, Herold-Mende C, Heikaus L, Sahm F, Wick W, Harter PN, von Deimling A, Reuss DE.
    Neuro Oncol; 2022 Dec 01; 24(12):2121-2132. PubMed ID: 35511748
    [Abstract] [Full Text] [Related]

  • 9. The Histopathologic and Radiologic Features of T2-FLAIR Mismatch Sign in IDH-Mutant 1p/19q Non-codeleted Astrocytomas.
    Fujita Y, Nagashima H, Tanaka K, Hashiguchi M, Hirose T, Itoh T, Sasayama T.
    World Neurosurg; 2021 May 01; 149():e253-e260. PubMed ID: 33610870
    [Abstract] [Full Text] [Related]

  • 10. Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted.
    Kikuchi K, Togao O, Yamashita K, Momosaka D, Kikuchi Y, Kuga D, Yuhei S, Fujioka Y, Narutomi F, Obara M, Yoshimoto K, Ishigami K.
    Neuroradiology; 2024 Mar 01; 66(3):333-341. PubMed ID: 38224343
    [Abstract] [Full Text] [Related]

  • 11. 11C-Methionine Integrated PET/MRI-Based Texture Analysis Features May Have a Potential Ability to Distinguish Oligodendroglioma (IDH-Mutant and 1p/19q-Codeleted) From Varied Gliomas.
    Zhao K, Yu P, Xue Z, Liu J, Yao A, Zhao Y, Yang F, Tian J, Xu B.
    Acad Radiol; 2020 Jul 01; 27(7):e159-e167. PubMed ID: 31607471
    [Abstract] [Full Text] [Related]

  • 12. Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.
    Park YW, Han K, Ahn SS, Bae S, Choi YS, Chang JH, Kim SH, Kang SG, Lee SK.
    AJNR Am J Neuroradiol; 2018 Jan 01; 39(1):37-42. PubMed ID: 29122763
    [Abstract] [Full Text] [Related]

  • 13. Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.
    Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, Letouzé E, Chinot O, Loiseau H, Honnorat J, Ramirez C, Moyal E, Figarella-Branger D, Ducray F, POLA Network.
    Neuro Oncol; 2014 May 01; 16(5):662-70. PubMed ID: 24353325
    [Abstract] [Full Text] [Related]

  • 14. MR textural analysis on T2 FLAIR images for the prediction of true oligodendroglioma by the 2016 WHO genetic classification.
    Rui W, Ren Y, Wang Y, Gao X, Xu X, Yao Z.
    J Magn Reson Imaging; 2018 Jul 01; 48(1):74-83. PubMed ID: 29140606
    [Abstract] [Full Text] [Related]

  • 15. MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.
    Patel SH, Batchala PP, Mrachek EKS, Lopes MS, Schiff D, Fadul CE, Patrie JT, Jain R, Druzgal TJ, Williams ES.
    Radiology; 2020 Jan 01; 294(1):160-167. PubMed ID: 31714193
    [No Abstract] [Full Text] [Related]

  • 16. MRI Features Can Predict 1p/19q Status in Intracranial Gliomas.
    Lasocki A, Gaillard F, Gorelik A, Gonzales M.
    AJNR Am J Neuroradiol; 2018 Apr 01; 39(4):687-692. PubMed ID: 29519793
    [Abstract] [Full Text] [Related]

  • 17. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS.
    Eur Radiol; 2020 Feb 01; 30(2):844-854. PubMed ID: 31446467
    [Abstract] [Full Text] [Related]

  • 18. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.
    Johnson DR, Diehn FE, Giannini C, Jenkins RB, Jenkins SM, Parney IF, Kaufmann TJ.
    AJNR Am J Neuroradiol; 2017 Apr 01; 38(4):678-684. PubMed ID: 28126746
    [Abstract] [Full Text] [Related]

  • 19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 20. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T, Tominaga T.
    J Neurooncol; 2016 Sep 01; 129(3):505-514. PubMed ID: 27401154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.